
Sign up to save your podcasts
Or


Sally Greenberg speaks with Gerald Dal Pan, M.D., Director of the FDA’s Office of Surveillance and Epidemiology, to explain how the FDA identifies drug safety signals, responds to emerging safety concerns and adherence challenges, and ensures ongoing protection for patients.
By District Productive3.5
44 ratings
Sally Greenberg speaks with Gerald Dal Pan, M.D., Director of the FDA’s Office of Surveillance and Epidemiology, to explain how the FDA identifies drug safety signals, responds to emerging safety concerns and adherence challenges, and ensures ongoing protection for patients.

140 Listeners

17 Listeners

1,811 Listeners

8,568 Listeners

97 Listeners

85 Listeners